IL1B and myeloid sarcoma: Additionally, MS patients have higher levels of IL-1β in both plasma and cerebrospinal fluid (CSF) (Dujmovic et al., 2009), and IL-1β levels are directly correlated with the degree of demyelination in the brain (Seppi et al., 2014).